Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial

NCT: NCT03820947 · TERMINATED

NCT IDNCT03820947
StatusTERMINATED
Start Date2020-02-05
Completion2025-11-10
SponsorMedtronic Endovascular (INDUSTRY)
First posted
Last updated

Brief Summary

Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early and Advanced Stage Superficial Venous Disease

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑